Prelude Capital Management’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.1K | Buy |
+22,816
| New | +$69.1K | 0.01% | 938 |
|
|
2022
Q2 | – | Sell |
-12,872
| Closed | -$66K | – | 1813 |
|
|
2022
Q1 | $66K | Sell |
12,872
-3,983
| -24% | -$20.4K | ﹤0.01% | 1175 |
|
|
2021
Q4 | $114K | Buy |
16,855
+3,700
| +28% | +$25K | ﹤0.01% | 1327 |
|
|
2021
Q3 | $91K | Buy |
13,155
+1,455
| +12% | +$10.1K | ﹤0.01% | 1163 |
|
|
2021
Q2 | $114K | Buy |
+11,700
| New | +$114K | ﹤0.01% | 1172 |
|
|
2018
Q1 | – | Sell |
-124
| Closed | -$9K | – | 1551 |
|
|
2017
Q4 | $9K | Buy |
+124
| New | +$9K | ﹤0.01% | 1080 |
|